Brian Holzer, MD, MBA

In addition to serving as the CEO of Lacuna Health, Dr. Holzer has been President of Kindred Innovations since June 2017. Kindred Innovations was born out of early success providing care management and home-based primary care solutions for patients across Kindred Healthcare’s divisions and post-acute continuum, and is uniquely positioned to deliver proven post-acute management solutions and services to hospitals and health systems, ACOs, clinically integrated networks, physician groups and post-acute care organizations who are seeking new and effective ways to manage post-acute care quality, outcomes and cost.

Dr. Holzer joined Kindred from Highmark Health, the third-largest integrated healthcare delivery and financing network in the nation. At Highmark, Dr. Holzer led the formation of HM Home and Community Services (“HMHCS”) and served as President of the organization. HMHCS was established in 2016 to be an innovator in post-acute management solutions, and has since helped drive improved clinical outcomes, better patient experience and a reduced overall cost of care for a Pennsylvania ACO and a health insurer’s Medicare Advantage line of business.

Dr. Holzer initially joined Highmark Health in 2013, first overseeing post-acute care operations at the Allegheny Health Network (“AHN”), a western Pennsylvania-based integrated healthcare delivery system. At AHN, Dr. Holzer led the development and operations of AHN Healthcare@Home, resulting in a hospital system-driven continuum of care model consisting of home health, hospice, home medical equipment and home infusion. Dr. Holzer has also held positions in healthcare consulting and various strategy, operations, and sales and marketing roles in the biotechnology industry. He received a medical degree from the Drexel School of Medicine and an MBA with a major in healthcare management from the Wharton School of Business.

Alicia Kelley Heazlitt, MBA, CNA

Alicia Kelley Heazlitt is a strategic business leader with over 15 years’ experience in market research and business development, actively supports entrepreneur access to customers and data to accelerate the development and adoption of innovative products, services and technologies in the post-acute market. Today she leads Corporate Development and Innovation for Signature HealthCARE and serves as the Chief Operations Officer for Signature Advantage, a Medicare Advantage Plan. Alicia assists in the management of Signature’s portfolio of companies while optimizing corporate investments that enhance market strength in the evolving healthcare environment. Signature HealthCARE is headquartered in Louisville, Kentucky, and is a family-owned, privately held company founded in 2007, now the 9th largest LTC provider in the United States, operating 143 affiliated LTC facilities in 10 states, and providing quality care for over 20,000 residents and their families.

Ms. Heazlitt helped build the first business accelerator and entrepreneurial hub in long term care, (InnovateLTC) for early-stage companies to have the market insights and access to customers servicing the care continuum. She has served on multiple boards and leadership groups including; Harbor House Executive Board, Louisville Innovation Summit, Health2.0 and AARP.

Karen Handmaker

Karen is an engaging population health management expert with a passion for new models and technologies to improve health and healthcare with the “consumer at the center.”

She is widely recognized for cultivating and maintaining strong, long term multi-level client relationships, strategic planning, thought leadership and industry knowledge. Karen is a passionate speaker, writer and trainer on population health management and primary care transformation. She earned admission into the IBM Industry Academy, is a NCQA PCMH Certified Content Expert, and a longtime member of the Population Health Management Journal Editorial Board.

Over the course of her career, Karen has worked at major healthcare and benefits consulting firms as well as technology and service companies delivering disease management, wellness and population health programs to employers, health plans and health systems.  Since 2010, she has specialized in provider-sponsored population health management and edited the second edition of Provider-Led Population Health Management, 2nd edition (2016).

Karen’s current areas of interest include integrating health and social care, enhancing personalized health and wellness through analytics and machine learning applications, championing and enabling market-driven products and services that produce measurable value across stakeholders.

Karen lived in Hong Kong for six years where she co-founded Fiscal Health, a first-of-a-kind local healthcare consulting firm offering a range of services in managed care and health economics.   Karen received a BA in American Studies at Trinity College in Hartford, CT (Phi Beta Kappa) and her Master in Public Policy from Harvard University.


Stephen C. Hanson, MPH


Stephen has over thirty years of C-suite experience in five health systems and four standalone hospitals serving seven states, including four years as CEO of Baptist Health KY/IN. Stephen is currently an executive in Residence at the University of Louisville School of Public Health and Information Sciences and a Fellow of the American College of Healthcare Executives.  Mr Hanson was a former Chair of the American Hospital Association Council on Health Systems. Stephen’s recent local volunteer involvement include Chair (with his wife) of the Metro United Way campaign, Chair and Vice Chair of Greater Louisville Inc., and Chair of the Health Enterprise Network. Mr. Hanson holds a Master of Public Health degree in health administration from the University of Oklahoma and earned his Bachelor of Science degree from Iowa State University.

Marty Bonick, MHA

Twitter LinkedIn

Marty Bonick, Chief Executive Officer, has over 20 years of leadership experience in both for‐profit and non‐profit settings. Prior to joining PhyMed, Mr. Bonick was president of division operations at Community Health Systems (CHS), overseeing a $4.5 billion portfolio of 36 hospitals and their associated clinics, outpatient centers, ambulatory surgery centers and urgent care operations across six states. Mr. Bonick also served as CEO of Jewish Hospital and Senior Vice President of Operations for Jewish Hospital & St. Mary’s Healthcare in Louisville, Ky. He has also held various leadership positions at Ardent Health Services, including CEO of Oklahoma State University Medical Center and VP of Operations for Hillcrest Medical Center in Tulsa, OK.

In 2011, Marty was the recipient of the Kentucky’s ACHE Early Career Executive Regent’s Award and in 2008 he was named an “Up and Comer” by Modern Healthcare magazine.

Marty is a Fellow in the American College of Healthcare Executives. He holds dual Master’s degrees from Washington University in St. Louis in Health Care Administration and Information Management and a Bachelor’s of Science degree in Psychology from the University of Illinois.

Carlos Rodarte


Twitter LinkedIn

Carlos is the Founder & Managing Director of Volar Health, LLC — an operations-focused consultancy that helps innovative health companies refine their product strategy and rapidly commercialize their solutions. Areas of expertise include digital health, wearables, biosensors, Internet-of-Things, and genomics. 

Previously, Carlos was co-founder & CEO of HealthRhythms, a digital health startup utilizing smartphone sensor technology to quantify behavioral health parameters. Beforehand, at PatientsLikeMe, the leading peer-to-peer research platform, he oversaw strategic partnerships with pharma and biotech, and developed the company’s wearables and biosensors capabilities. After spending 10,000+ hours as a consultant with The Frankel Group (acquired by Huron Consulting Group), Carlos developed a passion for direct-to-consumer healthcare models, identifying methods to engage patients in care, and generating clinical evidence through novel research methodologies. 

Carlos is an active startup mentor, member of several advisory boards, and recognized speaker on health innovation. In 2015, Carlos was named a “40 under 40 Healthcare Innovator” by MedTech Boston and in 2016 a “Top 100 Digital Health Influencer” by Onalytica.

Keisha Deonarine

Bio coming soon

Mark Arizmendi

mark ariz_final

Mark founded Northwestern Capital Partners, LLC in 2001 as an early stage and middle-market investment bank, focused on life sciences and agriculture.  The company has worked with some of nation’s largest institutional investors, and has completed transactions worth well over half a billion dollars since 2008.

The company is also an investor and manager for several of the start-ups it helped found or for which it raised capital, spanning geography from San Francisco to Boston.  Northwestern Capital Partners has provided both investment and management advice to dozens of companies, and has worked with venture capital investors, private equity firms, strategic investors, and angels.  The Company takes a honed approach, working deeply with a few clients at a time to develop strong relationships and provide long-term growth opportunities.

Mark attended the University of Southern California, majoring in economics, and has completed graduate programs at the McColl School of Business at Queen’s University and the Kellogg Graduate School of Management.  In addition to serving on the boards of several companies, Mark serves or has served on the Board of Ambassadors for the University of Southern California, where he earned the Widney Award for Alumni Leadership, the Georgetown Parent’s Council, Girls on the Run International, and as President and founder of the USC Alumni Board of the Carolinas, where he leads scholarship and philanthropy efforts.

Steve Clareen

Steven Spencer Clareen is a Life Sciences Executive that specializes in turnaround management as well as leading the commercialization of business units from start-up to established brand. Steve has diverse expertise in the biotechnology and medical device industries with experience in general management, business development, upstream and downstream marketing, sales and commercial operations. Most recently, Steve originated and led the integrated strategic and tactical commercial plans for the launch of DePuy Synthes Select™ across a broad range of customer segments (provider, physician and patient) at Johnson & Johnson. In 2013, Steve was recognized by the Becker’s Healthcare trade association as a Supply Chain Leader in the ambulatory surgery center industry.

Prior to Johnson & Johnson, Steve demonstrated success in business development and strategic planning roles for the Trauma Division at Synthes, a worldwide leader in orthopedics, spinal care and neuroscience. In this role, Steve led due diligence, structured and/or negotiated terms and conditions for new business opportunities with technology incubators, entrepreneurs, privately owned and university-affiliated companies. Earlier in his professional career, Steve held positions in Research and Development at Celgene Pharmaceuticals where he was an inventor on several patents and published in academic journals.

Steve received his M.B.A. in Finance and Marketing from The Johnson School at Cornell University and holds a M.S. in Organic Chemistry and B.A. in Inorganic Chemistry from Villanova University and Franklin & Marshal College, respectively.

David Dlugo


David Dlugo, Founder of D6 Product Development Consultants, LLC., brings with him almost 25 years of experience in complex engineering, regulatory and business leadership across various disciplines and groups within the Medical Device Industry. Over the years, he has achieved success for almost every US Fortune 500 medical device company. He also has worked closely with many start-up ventures helping them innovate first-to-market devices, position them for investors and expand their product portfolios. Much of his earlier experience was served in product development and manufacturing contract services.

David Dlugo, Founder of D6 Product Development Consultants, LLC., brings with him almost 25 years of experience in complex engineering, regulatory and business leadership across various disciplines and groups within the Medical Device Industry. Over the years, he has achieved success for almost every US Fortune 500 medical device company. He also has worked closely with many start-up ventures helping them innovate first-to-market devices, position them for investors and expand their product portfolios. Much of his earlier experience was served in product development and manufacturing contract services.